In addition, the monoclonal anti-IL-6R antibody tocilizumab increases apoptosis in cancer cells through the IL-6/Jak1/STAT3 axis, promoting tumorigenesis, invasion and antiapoptotic proteins expression in gastric cancer [132]. This evidence concerns the gene IL6 and cancer.